Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

792
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
792
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

405
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
405
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.3K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.3K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Construction of a ubiquitination-related gene prognostic model for breast cancer based on taxane treatment response].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2026
Same author

Electrically Accelerated Mechanochemical Film Formation by a Phosphonium Phosphate Ionic Liquid: An <i>In Situ</i> Chemical Kinetics Investigation.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Asymmetric Drug-Drug Interaction Prediction Based on Generative Adversarial Networks and Knowledge Graph.

Journal of computational biology : a journal of computational molecular cell biology·2026
Same author

Whole genome resequencing analysis of tobacco K326 and its cold sensitive mutant M18.

Frontiers in plant science·2026
Same author

Ditelluride-bridged, ROS-responsive nanoparticles based on carboxymethyl chitosan for potentiating doxorubicin chemotherapy.

Biomedical materials (Bristol, England)·2026
Same author

Performance-based classification of dialyzers: integrating YKL-40 for advanced middle-molecule clearance - A Chinese expert consensus.

Renal failure·2026
Same journal

Predicting piRNA-Disease Associations Based on Dual-View Learning and Multi-head Self-Attention Mechanism Fusion.

Interdisciplinary sciences, computational life sciences·2026
Same journal

DTANet+: Dual Interaction and Kernel-Diverse Network for Drug-Target Affinity Prediction.

Interdisciplinary sciences, computational life sciences·2026
Same journal

STNMAE: Identifying Spatial Domains from Spatial Transcriptomics Data with Neighbor-Aware Multi-view Masked Graph Autoencoder.

Interdisciplinary sciences, computational life sciences·2026
Same journal

Diagnosis and Prediction of Alzheimer's Disease via a High-Level Convolutional Block Attention Module-Residual Network.

Interdisciplinary sciences, computational life sciences·2026
Same journal

Deep3D-DTA: A Tri-Modal Deep Learning Framework for Binding Affinity Prediction Leveraging 3D Structural Representations of Drugs and Targets.

Interdisciplinary sciences, computational life sciences·2026
Same journal

ST-LDAW: A Topic-Model and Damped Weighted Least-Squares Method for Integrative Deconvolution of Single-Cell and Spatial Transcriptomics.

Interdisciplinary sciences, computational life sciences·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.6K

DisenKGE-DDI: A Knowledge Graph Embedding Framework Based on Disentangled Graph Attention Networks for Drug-Drug

Huimin Luo1,2, Linfei Hou1,2, Chaokun Yan1,2

  • 1School of Computer and Information Engineering, Henan University, Kaifeng, 475004, China.

Interdisciplinary Sciences, Computational Life Sciences
|April 20, 2026
PubMed
Summary
This summary is machine-generated.

Predicting drug-drug interactions (DDIs) is vital for patient safety. A new framework, DisenKGE-DDI, improves DDI prediction by considering both interaction direction and diversity, outperforming existing methods.

Keywords:
Disentangled graph attention networkDrug–drug interactionDual-layer attention mechanismKnowledge graphMutual information

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K

Related Experiment Videos

Last Updated: Apr 22, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

21.0K

Area of Science:

  • Pharmacology and Bioinformatics
  • Artificial Intelligence in Medicine
  • Computational Drug Discovery

Background:

  • Drug-drug interactions (DDIs) pose risks to therapeutic efficacy and patient safety.
  • Accurate DDI prediction is crucial for clinical safety and rational drug use.
  • Existing deep learning models for DDI prediction have limitations in capturing both interaction directionality and diversity.

Purpose of the Study:

  • To develop a novel framework, DisenKGE-DDI, for enhanced DDI prediction.
  • To address the limitations of existing methods by incorporating both micro- and macro-disentanglement mechanisms.
  • To improve the comprehensive modeling of pharmacological relationships for more accurate DDI prediction.

Main Methods:

  • Introduced DisenKGE-DDI, a framework based on a disentangled graph attention network.
  • Implemented micro-disentanglement using a factor-aware relation-based message aggregation and dual-layer attention.
  • Applied macro-disentanglement with mutual information regularization to ensure independence of semantic components.

Main Results:

  • DisenKGE-DDI demonstrated superior efficacy compared to state-of-the-art methods on public benchmark datasets.
  • The framework effectively captures intricate local semantic features and diverse interaction characteristics.
  • The proposed disentanglement mechanisms enhance the adaptiveness and comprehensiveness of drug embeddings.

Conclusions:

  • DisenKGE-DDI offers a significant advancement in DDI prediction accuracy and reliability.
  • The framework's ability to model both directional and diverse interaction aspects is key to its success.
  • This approach holds promise for improving drug safety and guiding clinical decision-making.